Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA Impurities
Crossref DOI link: https://doi.org/10.1208/s12249-019-1376-1
Published Online: 2019-04-15
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Charoo, Naseem Ahmad
Ali, Areeg Anwer
Buha, Shailesh Kumar
Rahman, Ziyaur
Text and Data Mining valid from 2019-04-15
Article History
Received: 4 February 2019
Accepted: 25 March 2019
First Online: 15 April 2019